Results 31 to 40 of about 8,089 (207)

Biomarkers of collagen turnover and wound healing in chronic thromboembolic pulmonary hypertension patients before and after pulmonary endarterectomy

open access: yes, 2023
Background: In chronic thromboembolic pulmonary hypertension (CTEPH), fibrotic remodeling of tissue and thrombi contributes to disease progression. Removal of the thromboembolic mass by pulmonary endarterectomy (PEA) improves hemodynamics and right ...
Andersen, Stine   +8 more
core   +1 more source

Life expectancy after pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension: a Swedish single-center study

open access: yesPulmonary Circulation, 2020
Pulmonary endarterectomy is the guideline recommended treatment for chronic thromboembolic pulmonary hypertension, in addition to life-long anticoagulation therapy.
Janica Kallonen   +4 more
doaj   +1 more source

Pulmonary artery blood flow dynamics in chronic thromboembolic pulmonary hypertension

open access: yesScientific Reports, 2023
Chronic thromboembolic pulmonary hypertension is caused by incomplete resolution and organization of thrombi. Blood flow dynamics are involved in thrombus formation; however, only a few studies have reported on pulmonary artery blood flow dynamics in ...
Hideo Tsubata   +8 more
doaj   +1 more source

Sex and survival following pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension: a Scandinavian observational cohort study

open access: yesPulmonary Circulation, 2021
Studies have suggested sex‐related survival differences in chronic thromboembolic pulmonary hypertension (CTEPH). Whether long‐term prognosis differs between men and women following pulmonary endarterectomy for CTEPH remains unclear.
Janica Kallonen   +7 more
doaj   +1 more source

Balloon pulmonary angioplasty for patients with chronic thromboembolic pulmonary hypertension previously operated by pulmonary endarterectomy

open access: yesPulmonary Circulation, 2022
Balloon pulmonary angioplasty improved hemodynamics, walking distance, and World Health Organization functional class in patients with chronic thromboembolic pulmonary hypertension not eligible for pulmonary endarterectomy (Non‐PEA) and patients with ...
Asger Andersen   +8 more
doaj   +1 more source

Case Report: Successful Concomitant Pulmonary Thromboendarterectomy and Carotid Endarterectomy

open access: yesFrontiers in Cardiovascular Medicine, 2022
Pulmonary thromboendarterectomy is the treatment of choice for chronic thromboembolic pulmonary hypertension. Pulmonary thromboendarterectomy concomitant with additional cardiac procedures was reported as safe and feasible.
Zhan Liu   +9 more
doaj   +1 more source

Pulmonary endarterectomy in chronic thromboembolic pulmonary hypertension

open access: yes, 2013
Conclusion: Pulmonary endarterectomy is effective and safe in the treatment of chronic thromboembolic pulmonary hypertension.
Mehmet Yanartas   +8 more
core   +2 more sources

Characteristics of chronic thromboembolic pulmonary hypertension in Ireland

open access: yesPulmonary Circulation, 2021
Chronic thromboembolic pulmonary hypertension (CTEPH) is a rare and under‐recognised complication of acute pulmonary embolism. Information regarding the characteristics of CTEPH in Ireland is limited, and the aim of this retrospective cohort study was to
Sarah Cullivan   +6 more
doaj   +1 more source

Balloon pulmonary angioplasty: a treatment option for inoperable patients with chronic thromboembolic pulmonary hypertension

open access: yesFrontiers in Cardiovascular Medicine, 2015
In chronic thromboembolic pulmonary hypertension, stenoses or obstructions of the pulmonary arteries due to organized thrombi can cause an elevation in pulmonary artery resistance, which in turn can result in pulmonary hypertension.
Aiko eOgawa, Hiromi eMatsubara
doaj   +1 more source

Larger pulmonary artery to ascending aorta ratios are associated with decreased survival of patients undergoing pulmonary endarterectomyCentral MessagePerspective

open access: yesJTCVS Open, 2022
Objectives: The ratio of pulmonary artery (PA) and ascending aorta (AA) diameters has recently been shown to be a useful indicator for disease severity and predictor of outcome in patients with pulmonary hypertension and heart failure.
Panja M. Boehm, MD   +12 more
doaj   +1 more source

Home - About - Disclaimer - Privacy